Senseonics Holdings Inc (SENS) News, Articles, Events & Latest Updates
Find Senseonics Holdings Inc (SENS) news, corporate events, press releases, latest company updates and headlines
stocktwits.comHere are the latest headlines on Senseonics (SENS) as of now:
- Senseonics announces European launch of Eversense 365, the world’s first one-year CGM, with initial rollout in Sweden and planned expansions to Germany, Spain, and Italy in the coming weeks. This follows CE Mark approval earlier in 2026 and prior FDA clearance in 2024.[1]
- Senseonics reports Q4 and full-year 2025 results, highlighting revenue growth and progress toward EU commercialization, including CE Mark for Eversense 365 and ongoing enrollment in pivotal trials. These results accompany updates on EU launches and integration milestones.[1]
- Additional coverage notes European approvals enabling commercialization across the EU and mentions expansion plans to other major markets, aiming to broaden the patient population and integration with automated insulin delivery systems.[1]
If you’d like, I can pull the most recent articles from specific outlets (e.g., GlobeNewswire, MarketBeat, or StockTwits) and summarize them with links. I can also set up a quick alert plan (e.g., daily briefing or weekly digest) for SENS news.